BridgeBio Pharma, Inc.

BBIO· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$79.96-0.16%

2026-08-03

Financials

Valuation Metrics

BridgeBio Pharma, Inc.'s Market Cap is $15.66B. At end of 2025 it was $15.09B. Ranked #710 of 3,112 in US market (top 23%), #222 of 1,445 on NASDAQ (top 15%), #33 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 12%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$15.66B	US#710/3,112 Sec#33/269
Revenue	$580M	US#2,272/3,112 Sec#74/269
Net Income	$-726M	US—/3,112 Sec—/269
Total Assets	$1.37B	US#2,292/3,112 Sec#74/269
Net Assets	$-2.27B	US#3,059/3,112 Sec#272/269
Value
P/S	27.00x	US#2,846/3,112 Sec#156/269
FCF Yield	-2.90%	US—/3,112 Sec—/269
Profitability
ROA	-52.95%	US#2,979/3,112 Sec#225/269
Op. Margin	-98.40%	US#2,822/3,112 Sec#123/269
Revenue Growth	66.78%	US#221/3,112 Sec#45/269
Financial Health
Total Debt	$3.38B	US#862/3,112 Sec#27/269
FCF	$-454M	US#2,827/3,112 Sec#257/269
Cash	$880M	US#761/3,112 Sec#35/269
Current Ratio	1.44x	US#1,723/3,112 Sec#246/269
Performance
1Y Return	68.80%	US#515/3,112 Sec#102/269
1M Return	3.59%	US#1,118/3,112 Sec#43/269
From 52W High	-14.41%	US#1,370/3,112 Sec#81/269
1Y MDD	-20.25%	US#698/3,112 Sec#28/269
Trading
Volume	1,293,475 shares	US#1,255/3,112 Sec#122/269
Trading Value	$103M	US#882/3,112 Sec#53/269
Per Share
EPS	$-3.70	US—/3,112 Sec—/269